| OPUS GENETICS DL-,0001 |
| USA |
| Gesundheit |
| US67577R1023 / A2QG4Z |
| R3X1 (Frankfurt) |
| FRA:R3X1, ETR:R3X1, R3X1:GR |
| - |
| https://opusgtx.com/ |
|
Opus Genetics Inc. is a biotechnology company focusing on developing innovative gene therapies for i..
>Volltext.. |
| 195.89 Mio. EUR |
| 170.51 Mio. EUR |
| 12.3 Mio. EUR |
| -31.2 Mio. EUR |
| -57.32 Mio. EUR |
| -1.44 EUR |
| 0.9 Mio. EUR |
| 25.9 Mio. EUR |
| -27.61 Mio. EUR |
| 1.06 |
| 65.67% |
| -137.99% |
| - |
| - |
| - |
| - |
| OPUS GENETICS |
| 13.02.26 |
|